Search Results - David M Nathan

Refine Results
  1. 1
    Rosiglitazone and Cardiotoxicity — Weighing the Evidence

    Rosiglitazone and Cardiotoxicity — Weighing the Evidence by David M. Nathan

    Published 2007
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

    International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes by David M. Nathan

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview by David M. Nathan

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Realising the long-term promise of insulin therapy: the DCCT/EDIC study

    Realising the long-term promise of insulin therapy: the DCCT/EDIC study by David M. Nathan

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Associati... by David M. Nathan

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions

    Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions by Linda M. Delahanty, David M. Nathan

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)

    Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of... by John M. Lachin, David M. Nathan

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Relationship between glycated haemoglobin levels and mean glucose levels over time

    Relationship between glycated haemoglobin levels and mean glucose levels over time by David M. Nathan, Heather Turgeon, Susan Regan

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals

    Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals by Nancy Wei, Hui Zheng, David M. Nathan

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer

    Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer by Matthew R. Smith, Hang Lee, David M. Nathan

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7%

    Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7% by Lydie Pani, David M. Nathan, Richard W. Grant

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring

    Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring by Roy Malka, David M. Nathan, John M. Higgins

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

    The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes by John M. Lachin, Ionut Bebu, David M. Nathan

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Psychological Predictors of Physical Activity in the Diabetes Prevention Program

    Psychological Predictors of Physical Activity in the Diabetes Prevention Program by Linda M. Delahanty, Molly B. Conroy, David M. Nathan

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

    Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study by John M. Lachin, Trevor J. Orchard, David M. Nathan

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer

    Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer by Matthew Smith, Hang Lee, Mary Anne Fallon, David M. Nathan

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial

    The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial by John M. Lachin, Saul Genuth, David M. Nathan, Brandy Rutledge

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population

    Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population by Adit A. Ginde, Enrico Cagliero, David M. Nathan, Carlos A. Camargo

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Intensification of diabetes medication and risk for 30‐day readmission

    Intensification of diabetes medication and risk for 30‐day readmission by Nancy Wei, Deborah J. Wexler, David M. Nathan, Richard W. Grant

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?

    Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? by R.J. Heine, M. Diamant, Jean Claude Mbanya, David M. Nathan

    Published 2006
    Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: